| Literature DB >> 24936428 |
Luca Cocchi1, Ian H Harding2, Anton Lord3, Christos Pantelis2, Murat Yucel4, Andrew Zalesky5.
Abstract
Neuroimaging studies have demonstrated that the phenomenology of schizophrenia maps onto diffuse alterations in large-scale functional and structural brain networks. However, the relationship between structural and functional deficits remains unclear. To answer this question, patients with established schizophrenia and matched healthy controls underwent resting-state functional and diffusion weighted imaging. The network-based statistic was used to characterize between-group differences in whole-brain functional connectivity. Indices of white matter integrity were then estimated to assess the structural correlates of the functional alterations observed in patients. Finally, group differences in the relationship between indices of functional and structural brain connectivity were determined. Compared to controls, patients with schizophrenia showed decreased functional connectivity and impaired white matter integrity in a distributed network encompassing frontal, temporal, thalamic, and striatal regions. In controls, strong interregional coupling in neural activity was associated with well-myelinated white matter pathways in this network. This correspondence between structure and function appeared to be absent in patients with schizophrenia. In two additional disrupted functional networks, encompassing parietal, occipital, and temporal cortices, the relationship between function and structure was not affected. Overall, results from this study highlight the importance of considering not only the separable impact of functional and structural connectivity deficits on the pathoaetiology of schizophrenia, but also the implications of the complex nature of their interaction. More specifically, our findings support the core nature of fronto-striatal, fronto-thalamic, and fronto-temporal abnormalities in the schizophrenia connectome.Entities:
Keywords: Brain connectivity; DTI; Diffusion; Psychosis; Resting-state; Structure–function; fMRI
Mesh:
Year: 2014 PMID: 24936428 PMCID: PMC4055899 DOI: 10.1016/j.nicl.2014.05.004
Source DB: PubMed Journal: Neuroimage Clin ISSN: 2213-1582 Impact factor: 4.881
Participant demographics.
| SCZ (n = 17) | CON (n = 17) | Statistic | |
|---|---|---|---|
| Demographics, mean (SD) | |||
| ????Age, years | 29.9 (6.7) | 27.0 (6.1) | |
| ????Gender, M/F | 16/1 | 13/4 | ?2 = 2.11, |
| ????Education, years | 13.6 (3.0) | 14.6 (1.8) | |
| ????Full-scale IQ | 104 (14.9) | 113 (6.1) | |
| ????Handedness, R/L | 15/2 | 17/0 | ?2 = 2.13, |
| Illness and symptom measures, mean (SD) or median [range] | |||
| ????Age of initial diagnosis, years | 22.5 (4.5) | ||
| ????Treatment duration, years | 7.5 (4.9) | ||
| ????PANSS positive | 13.4 (6.4) | ||
| ????PANSS negative | 12.3 (4.5) | ||
| ????PANSS general | 27.6 (6.2) | ||
| ????Beck Depression Inventory | 16 [0–41] | 2 [0–14] | |
| ????Beck Anxiety Inventory | 7 [0–36] | 2 [0–5] | |
| ????Quality of life | 58.4 (12.2) | 70.3 (6.7) | |
| Substance use measures, median [range] | |||
| ????Alcohol, current drinks/month | 2 [0–80] | 9 [0–72] | |
| ????Tobacco, current cigs/day | 0 [0–30] | 0 [0–15] | |
| ????Cannabis, lifetime uses | 77 [0–3650] | 10 [0–700] | |
| ????Ecstasy, lifetime uses | 1 [0–156] | 0 [0–30] | |
| ????Amphetamines, lifetime uses | 0 [0–365] | 0 [0–4] | |
| ????Cocaine, lifetime uses | 0 [0–6] | 0 [0–15] | |
| ????Hallucinogens, lifetime uses | 0 [0–8] | 0 [0–5] | |
Bold entries denote statistical significance; PANSS = Positive and Negative Syndrome Scale.
IQ not measured for 1 control and 3 schizophrenia participants.
Quality of Life Enjoyment and Satisfaction Scale (abbreviated version).
Fig. 1Within each functional network of interest, the average fractional anisotropy (FA) between constituent region-pairs was estimated to provide connection and network-level indices of structural connectivity for each subject. Depicted here are examples of white-matter tractography between 5 region-pairs (relevant to Network 1) in healthy controls and patients with schizophrenia. Visual inspection of tractography outputs was important to exclude problems in fibre tracking. However, our analysis focused on network-level differences and do not allow to declare changes at the level of single connections. Results from confirmatory analyses at the resolution of single connections can be found in Supplementary Fig. 2 (a = #20, b = #19, c = #1, d = #6, e = #22).
Fig. 2Patients with schizophrenia showed decreased functional connectivity in two distinct brain networks (Network 1 and Network 2). Network 1 encompassed pairwise connectivity between frontal, fronto-temporal, and fronto-striatal regions. Network 2 comprised occipito-parietal, occipito-temporal, and parietal–temporal interactions. In a third network (Network 3), encompassing parieto-temporal connections, patients showed increased functional connectivity compared to healthy controls.
Fig. 3A significant breakdown in the normal relationship between functional and structural brain connectivity was identified only in Network 1. A significant positive association between functional and structural connectivity was found in healthy participants, while this relationship was lost in patients with schizophrenia. In addition, in Network 1, patients with schizophrenia showed a trend-level reduction in fractional anisotropy (FA) compared to healthy controls (*p = 0.057; Cohen's d = 0.59).